| |
 |
|
|
Inventor: Warren; Stephen T.
Address: Atlanta, GA
No. of patents: 3
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7432052 |
Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrom |
October 7, 2008 |
| Compositions and methods for identifying and/or modulating RNA transcripts and/or genes involved in fragile X syndrome and other associated disorders are provided. In particular, RNA targets for fragile X mental retardation protein (FMRP) have been identified by a novel monoclonal an |
| 6916821 |
Methods of treating disorders with Group I mGluR antagonists |
July 12, 2005 |
| mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retar |
| 6890931 |
Methods of treating disorders with group I mGluR antagonists |
May 10, 2005 |
| Compositions and uses of mGluR5 antagonists for the treatment and prevention of neurological disorders, such as Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome, are disclosed. |
|
|
|
